Pacific Biosciences of California Debt 2024

Pacific Biosciences of California Aktienanalyse

What does Pacific Biosciences of California do?

Pacific Biosciences of California Inc is an American biotechnology company specializing in the development of systems for DNA sequencing and genome research. The company was founded in 2004 and is headquartered in Menlo Park, California. The company was founded by biochemist Stephen Turner, who had previously worked at Illumina, a leading company in genome research. The goal was to develop a new technology for DNA sequencing that would be faster and more accurate than existing systems. In 2005, the company received investments from notable venture capitalists such as Mohr Davidow Ventures, Alloy Ventures, and Kleiner Perkins Caufield & Byers. In 2010, Pacific Biosciences released its first commercial DNA sequencing system. The business model of Pacific Biosciences is based on the development and marketing of DNA sequencing systems and related products and services. The company offers standalone devices as well as integrated solutions for genome research to its customers, including research and diagnostic laboratories. Pacific Biosciences focuses on long-term customer relationships and the continuous advancement of its technologies. Pacific Biosciences operates in two main business segments: research and diagnostics. In the research segment, the company offers DNA sequencing systems that help researchers decipher the DNA of individual cells and complex genomes. These systems enable scientists to deepen their understanding of molecular-level biological processes and diseases. In the diagnostics segment, Pacific Biosciences develops solutions for personalized medicine and application in clinical laboratories. The main product of Pacific Biosciences is the PacBio RS II DNA sequencing platform. This system is based on the single-molecule sequencing technology, which offers high accuracy and reading speed. The PacBio RS II is a fully integrated device that performs both DNA preparation and sequencing, simplifying the entire workflow. In addition, Pacific Biosciences also offers a variety of products and services tailored to the needs of its customers. These include DNA extraction kits, sequencing software, and analysis tools. In summary, Pacific Biosciences of California is a biotechnology company specializing in the development of systems for DNA sequencing and genome research. Founded in 2004, the company is headquartered in Menlo Park, California. Pacific Biosciences operates in two main business segments, research and diagnostics, and offers a variety of products and services tailored to the needs of its customers. The main product of Pacific Biosciences is the PacBio RS II DNA sequencing platform, based on single-molecule sequencing technology. Pacific Biosciences of California ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Pacific Biosciences of California's Debt Structure

Pacific Biosciences of California's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Pacific Biosciences of California's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Pacific Biosciences of California’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Pacific Biosciences of California’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Pacific Biosciences of California stock

What is the debt of Pacific Biosciences of California this year?

Pacific Biosciences of California has a debt level of 261.82 USD this year.

What was the debt of Pacific Biosciences of California compared to the previous year?

The debt of Pacific Biosciences of California has increased by -54.38% compared to the previous year dropped.

What are the consequences of high debt for investors in Pacific Biosciences of California?

High debt can pose a risk for investors of Pacific Biosciences of California, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Pacific Biosciences of California?

Low debt means that Pacific Biosciences of California has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Pacific Biosciences of California affect the company?

An increase in debt of Pacific Biosciences of California can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Pacific Biosciences of California affect the company?

A reduction in debt of Pacific Biosciences of California can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Pacific Biosciences of California?

Some factors that can influence the debt of Pacific Biosciences of California include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Pacific Biosciences of California so important for investors?

The debts of Pacific Biosciences of California are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Pacific Biosciences of California take to change the debt?

To change the debt, Pacific Biosciences of California can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Pacific Biosciences of California pay?

Over the past 12 months, Pacific Biosciences of California paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pacific Biosciences of California is expected to pay a dividend of 0 USD.

What is the dividend yield of Pacific Biosciences of California?

The current dividend yield of Pacific Biosciences of California is .

When does Pacific Biosciences of California pay dividends?

Pacific Biosciences of California pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pacific Biosciences of California?

Pacific Biosciences of California paid dividends every year for the past 0 years.

What is the dividend of Pacific Biosciences of California?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pacific Biosciences of California located?

Pacific Biosciences of California is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pacific Biosciences of California kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pacific Biosciences of California from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.

When did Pacific Biosciences of California pay the last dividend?

The last dividend was paid out on 7/7/2024.

What was the dividend of Pacific Biosciences of California in the year 2023?

In the year 2023, Pacific Biosciences of California distributed 0 USD as dividends.

In which currency does Pacific Biosciences of California pay out the dividend?

The dividends of Pacific Biosciences of California are distributed in USD.